(Q50938578)

25 March 2018

title

"Wanting to be a good father": experiences of adolescent fathers of Mexican descent in a teen fathers program. (English)

1 reference

25 March 2018

1 reference

José Rubén Parra-Cardona

series ordinal

1

1 reference

25 March 2018

Richard S Wampler

series ordinal

2

1 reference

25 March 2018

Elizabeth A Sharp

series ordinal

3

1 reference

25 March 2018

publication date

1 April 2006

1 reference

25 March 2018

Journal of Marital & Family Therapy

published in

1 reference

25 March 2018

volume

32

1 reference

25 March 2018

issue

2

1 reference

25 March 2018

page(s)

215-231

1 reference

25 March 2018

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Employees with overactive bladder: work loss burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

A neurologic basis for the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

A myogenic basis for the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Pathophysiology of the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

More than just a barrier: urothelium as a drug target for urinary bladder pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Bladder activation: afferent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Management of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Muscarinic receptor antagonists in the treatment of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Antimuscarinics and the overactive detrusor--which is the main mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Recent advances in basic science for overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Clinical pharmacokinetics of trospium chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Trospium chloride: A quaternary amine with unique pharmacologic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Antimuscarinics for treatment of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Multicenter phase III trial studying trospium chloride in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Time to onset of improvement in symptoms of overactive bladder using antimuscarinic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

Behavioral vs Drug Treatment for Urge Urinary Incontinence in Older Women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.2.215

21 January 2018

Identifiers

DOI

10.2217/14750708.3.2.215

1 reference

25 March 2018

1 reference

25 March 2018